Kim Blackwell currently serves on the Board of Directors for several organizations, including Susan G. Komen, Fore Biotherapeutics, Century Therapeutics, and Monte Rosa Therapeutics. Additionally, Kim Blackwell held the position of Chief Executive Officer at Zentalis Pharmaceuticals and served as Chief Medical Advisor and Chief Medical Officer at Tempus Labs. Prior roles include Vice President at Eli Lilly and Professor at Duke University Medical Center. Kim Blackwell's educational background includes a Doctor of Medicine from Mayo Clinic Alix School of Medicine, a Medical Oncology Residency, and a Bachelor's degree in Bioethics/Medical Ethics from Duke University.
This person is not in the org chart
This person is not in any teams